PanGen Biotech Inc. (KOSDAQ: 222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,640.00
+40.00 (0.71%)
Dec 19, 2024, 1:50 PM KST

PanGen Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
72,74673,46269,40599,78397,86474,917
Upgrade
Market Cap Growth
-23.33%5.85%-30.44%1.96%30.63%-26.00%
Upgrade
Enterprise Value
69,04074,76767,44692,63896,12165,917
Upgrade
Last Close Price
5640.006880.006500.009350.0010150.007770.00
Upgrade
Forward PE
-91.3091.3091.3091.3091.30
Upgrade
PS Ratio
4.5410.0410.6812.5715.8126.00
Upgrade
PB Ratio
3.575.854.034.736.894.07
Upgrade
P/TBV Ratio
2.716.294.094.807.024.13
Upgrade
EV/Sales Ratio
5.0310.2210.3811.6715.5322.88
Upgrade
Debt / Equity Ratio
0.130.160.000.891.290.94
Upgrade
Debt / EBITDA Ratio
1.60-----
Upgrade
Asset Turnover
0.570.350.200.200.160.07
Upgrade
Inventory Turnover
1.170.941.061.822.127.79
Upgrade
Quick Ratio
1.630.421.551.280.971.30
Upgrade
Current Ratio
3.301.727.591.571.201.35
Upgrade
Return on Equity (ROE)
-3.65%-30.14%-23.46%-18.75%-26.69%-39.40%
Upgrade
Return on Assets (ROA)
-0.18%-12.75%-8.97%-5.16%-6.14%-11.77%
Upgrade
Return on Capital (ROIC)
-0.23%-16.61%-10.06%-5.68%-6.76%-12.64%
Upgrade
Earnings Yield
-1.02%-6.11%-6.47%-3.32%-4.45%-11.93%
Upgrade
FCF Yield
0.58%-5.27%-6.10%-4.76%-5.56%-5.98%
Upgrade
Buyback Yield / Dilution
-3.61%-0.03%-4.47%-6.02%0.04%-0.16%
Upgrade
Total Shareholder Return
-3.61%-0.03%-4.47%-6.02%0.04%-0.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.